Advances in the management of ADHD in children and adolescents
Listen to this summary
This review aims to synthesize recent evidence on the management of ADHD in children and adolescents, highlighting the need for individualized and sustained care due to the condition's chronic and fluctuating nature. It discusses the effectiveness of various diagnostic strategies and treatment modalities, including psychosocial interventions, lifestyle changes, and pharmacological options, while emphasizing a multimodal approach aligned with international guidelines. The findings underscore the importance of personalized treatment strategies, particularly in pharmacological management, to improve outcomes for affected individuals.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.
More from BMJ (Clinical research ed.)
View all →Jun 24, 2026 · BMJ (Clinical research ed.)
Assessing early effects of Australia's Social Media Minimum Age Act on adolescents' social media use: observational study
Jun 18, 2026 · BMJ (Clinical research ed.)
Stereotactic radiotherapy for neovascular age related macular degeneration: year 3 and 4 extended follow up results of a randomised, double masked, sham controlled, device trial (STAR)
Jun 15, 2026 · BMJ (Clinical research ed.)
Advances in the development of malaria vaccines
Jun 11, 2026 · BMJ (Clinical research ed.)
Low concentration atropine eye drops and progression of myopia in children: multicentre placebo controlled, double masked, randomised trial in the UK (CHAMP-UK)
Jun 10, 2026 · BMJ (Clinical research ed.)
Advances in supporting development in autistic children and youth
Jun 4, 2026 · BMJ (Clinical research ed.)
Global, regional, and national levels and trends in under 5, infant, and neonatal mortality during 1990-2024 with scenario based projections to 2030: modelling study
More in Internal Medicine
View all →Jun 25, 2026 · Blood
Combining Quizartinib with intensive chemotherapy in older patients with newly diagnosed AML: results of the UK NCRI AML18 Trial
Jun 25, 2026 · Blood
Translational Regulation of Sf1 Integrates Alternative Splicing and Hematopoietic Stem Cell Fate
Jun 25, 2026 · Blood
Galectin-1 Fuels Monocyte Hyperinflammation and Represents a Novel Therapeutic Target in Myeloproliferative Neoplasms
Jun 25, 2026 · The American journal of sports medicine
Association of Central Acetabular Osteophytes With Microinstability and Increased Combined Anteversion in Borderline Dysplasia Hips
Jun 25, 2026 · Blood
NG2-ITGA4 axis regulates Rho GTPases and leukemic aggressiveness in KMT2A-r B-ALL and is targetable with natalizumab
Jun 24, 2026 · Lancet (London, England)
Safety, pharmacokinetics, and exploratory efficacy of the oral ghrelin receptor agonist AC01 in heart failure with reduced ejection fraction (GOAL-HF1): a randomised, double-blind, placebo-controlled, phase 1b/2a study
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR
Stay current without falling behind
33,000+ journals. 3-minute audio summaries. Free for 14 days.
